Co-Producer
|
|
|
|
|
| *
- may be subscription-only |
|
|
- BriaCell: Second Data Safety Monitoring Board
Issues Positive Recommendation to Continue Phase 3
Study in Metastatic Breast Cancer More
- iECURE: Presentation of Full Data for the First
Infant Dosed With ECUR-506 in OTC-HOPE Phase 1/2
Clinical Trial at the 2025 ACMG Annual Clinical
Genetics Meeting More
- Johnson & Johnson: U.S. FDA Approves
TREMFYA (Guselkumab), the First and Only Il-23
Inhibitor Offering Both Subcutaneous and
Intravenous Induction Options, for Adult Patients
With Moderately to Severely Active Crohn’s Disease
More
- Napigen: USDA Informs NAPIGEN, Inc. Its CMS Rice
is Not Subject to Regulation More
- STRATA Skin Sciences: Highlights New Clinical
Study From Japan Demonstrating Superiority of Narrow
Band Excimer Laser Over Non Narrow Band UVB-Source
Like Excimer Light More
- The Wistar Institute: Appoints Three New Members
to Its Board of Trustees More
- Traws Pharma: Bird Flu Drug Candidate, Tivoxavir
Marboxil, Presented at ICAR More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
|
- Avalo: 2024 Financial Results and Recent Business
Updates More
- Context Therapeutics: Full Year 2024 Operating and
Financial Results More
- LSN: Hot Investor Mandates (Updated 03/18) More
- Lungpacer Medical Will Nearly Double Workforce to
Support First Product Launch More*
- More on Paratek Acquiring Optinose, Expanding
Portfolio Beyond Antibiotics More*
More*
More
- Soligenix: Recent Accomplishments and Year End 2024
Financial Results More
- TELA Bio: Fourth Quarter and Full Year 2024
Financial Results More
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Adaptimmune, After Bringing Cell Therapy to
Market, Questions Viability and Cuts 2 Preclinical
Programs More
- Gene Therapies and CRISPR Drugs Slowed by
‘Irrational Pessimism,’ Say Scientists Forging New
Paths More*
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
|
|
|
Section
Sponsor:
|
|
|
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Philadelphia Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
- OPPORTUNITY: Head of CMC More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Chief Medical Officer More
- OPPORTUNITY: Department Chair of Vascular Surgery More
- OPPORTUNITY: Vice President of Enterprise More
- OPPORTUNITY: Head of Operations More
- OPPORTUNITY: Vice President of Clinical Affairs More
- OPPORTUNITY: Laboratory Leader More
- OPPORTUNITY: Senior Manufactuing Engineer More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
